Drug Advertising’s Shift To The Web Will Be Sped By Better Metrics – Merck
Executive Summary
Uptake of Internet-based advertising for pharmaceuticals could be increased with better ways to measure the impact of the ads, Merck Executive Director of E-Business Strategies & Solutions Melanie Kittrell said
You may also be interested in...
Risk Disclosure In Drug Ads Will Be FDA’s Focus After House Defeats DTC Ban
The revised language on direct-to-consumer advertising in the FDA safety bills pending in Congress no longer allows the agency to ban ads, but creates a number of new disclosure requirements for the spots
Risk Disclosure In Drug Ads Will Be FDA’s Focus After House Defeats DTC Ban
The revised language on direct-to-consumer advertising in the FDA safety bills pending in Congress no longer allows the agency to ban ads, but creates a number of new disclosure requirements for the spots
AstraZeneca Takes Five: DTC Study Finds Five Risks Per Ad Is Optimal For Recall
An AstraZeneca study on consumer communication through direct-to-consumer television advertisements identifies five risks as the optimal number to include in order to ensure consumer recall of safety information